BCC 2023 | Multiplexed analysis and spatial histology to predict response to immunotherapy in breast cancer

Marleen Kok, MD, PhD, Netherlands Cancer Institute, Amsterdam, Netherlands, discusses spatial analysis in breast cancer to predict outcomes to immunotherapy, providing an overview of spatial analysis techniques as well as clinical trials evaluating spatial analysis including IMpassion130 (NCT02425891), I-SPY (NCT01042379) and NeoTRIP (NCT02620280) trials. This interview took place at the St. Gallen International Breast Cancer Consensus Meeting in Vienna, Austria.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.